October 2018: OncoMark attending ESMO

Members of the OncoMark team will be attending the European Society of Medical Oncology 2018 Congress in Munich, Germany, from the 19th- 22nd October.

Mr. Des O’Leary (CEO), Mr William Gallagher (Chief Scientific Officer) and Mr Tony Loughman (Senior Product Development Scientist) will be in attendance. A poster entitled “Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer” (Ref 204P) will be presented by Mr Tony Loughman. The poster presentation will be held on Monday 22nd October, with a dedicated viewing from 12:45-13:45.

Please visit this poster to hear more about OncoMasTR and to engage with the OncoMark team.